Evidence map›Paper›PMID 42639040›Full record

ArticleCase reports in cardiology2026

Treatment of Early Trilogy Valve Aortic Insufficiency With Valve-in-Valve Transcatheter Aortic Valve Replacement.

Johan van Nispen, Michael Massoomi, Eric Jeng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Johan van NispenDepartment of Surgery, Division of Cardiac Surgery, University of Florida, Gainesville, Florida, USA, ufl.edu.ORCID https://orcid.org/0000-0002-4157-118X
Michael MassoomiDepartment of Medicine, Division of Cardiology, University of Florida, Gainesville, Florida, USA, ufl.edu.ORCID https://orcid.org/0000-0002-3677-6543
Eric JengDepartment of Surgery, Division of Cardiac Surgery, University of Florida, Gainesville, Florida, USA, ufl.edu.ORCID https://orcid.org/0000-0002-3824-9958

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aortic insufficiency (AI) is the third most common left valvular heart disease. Transcatheter aortic valve replacement (TAVR) is becoming popular in the treatment of AI. The Trilogy Valve (JenaValve Technology, Irvine, California, United States) is in clinical trials. We report here a case of valve-in-valve TAVR with a Sapien S3 Ultra Resilia valve (Edwards Lifesciences Corporation, Irvine, California, United States) for recurrent AI after Trilogy valve placement.

Indexed as

TAV in TAVTrilogy valveViV TAVR

Identifiers

PMID42639040
PMCPMC13501502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.